Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with Combat Post-traumatic Stress Disorder.
adherence
post-traumatic
psychometric
reliability
screening
stress disorders
therapeutics
validity
Journal
Patient preference and adherence
ISSN: 1177-889X
Titre abrégé: Patient Prefer Adherence
Pays: New Zealand
ID NLM: 101475748
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
10
4
2019
pubmed:
10
4
2019
medline:
10
4
2019
Statut:
epublish
Résumé
Treatment adherence is one of the major strategies in treating post-traumatic stress disorder (PTSD) in combat veterans. This study developed and psychometrically assessed the Treatment Adherence Questionnaire for Patients with Combat Post-Traumatic Stress Disorder. This methodological study was conducted in Tehran, Iran, during 2016-2017 in two phases. First, the concept of treatment adherence in combatants with PTSD was analyzed using a hybrid model. This model consisted of three phases: literature review phase, fieldwork phase, and final analysis phase. The consequences and attributes of the concept of treatment adherence in combatants with PTSD were identified, and based on the findings, the Treatment Adherence Questionnaire for PTSD veterans was developed. In the second stage, the face and content validities of the questionnaire were investigated both quantitatively and qualitatively. Exploratory factor analysis and confirmatory factor analysis were used to determine the questionnaire's validity. Internal consistency correlation coefficient of the questionnaire was estimated with Cronbach's alpha coefficient, while the reliability of the questionnaire was established using intra-class test-retest correlation coefficient. Study participants were selected from inpatients and outpatients referred to a hospital, clinic, and health center in Tehran and Kashan, Iran. All patients were diagnosed with combat PTSD by a psychiatrist, based on psychiatric interview and other clinical findings. The Persian version of the Treatment Adherence Questionnaire for Patients with Combat Post-Traumatic Stress Disorder included 17 items. Exploratory factor analysis identified three factors which accounted for a total of 87.57% of the total variance of treatment adherence score. The identified factors were labeled as "maintenance of treatment", "follow-up and treatment contribution", and "purposefulness and responsibility". The Cronbach's alpha correlation coefficient was 0.92 and the intra-class correlation coefficient of the questionnaire's reliability was estimated at 0.92 ( The data obtained confirmed the hypothesis of the factor structure model with a latent second-order variable. The final version of the Treatment Adherence Questionnaire for Iranian combatants with PTSD can be applied as a valid and reliable questionnaire for measuring treatment adherence in these patients.
Identifiants
pubmed: 30962678
doi: 10.2147/PPA.S175353
pii: ppa-13-419
pmc: PMC6434911
doi:
Types de publication
Journal Article
Langues
eng
Pagination
419-430Déclaration de conflit d'intérêts
Disclosure The authors report no conflicts of interest in this work.
Références
Nurse Educ Today. 2004 Feb;24(2):105-12
pubmed: 14769454
J Nerv Ment Dis. 2005 Aug;193(8):515-22
pubmed: 16082295
Diabet Med. 2006 Jul;23(7):720-8
pubmed: 16842475
J Evid Based Soc Work. 2009 Jan;6(1):4-16
pubmed: 19199133
Clin Psychol Rev. 2009 Dec;29(8):727-35
pubmed: 19744758
Arch Gen Psychiatry. 2010 Jun;67(6):608-13
pubmed: 20530010
J Psychosom Res. 2010 Dec;69(6):591-9
pubmed: 21109048
J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):90-4
pubmed: 21247831
J Behav Med. 2012 Feb;35(1):8-18
pubmed: 21318411
BMC Med Inform Decis Mak. 2012 Aug 02;12:83
pubmed: 22856325
Am J Psychiatry. 2013 Jan;170(1):59-70
pubmed: 23111466
J Sex Med. 2014 Jan;11(1):75-83
pubmed: 23679562
Behav Sci (Basel). 2014 Dec 08;4(4):511-527
pubmed: 25494488
PLoS One. 2015 Mar 20;10(3):e0120270
pubmed: 25793582
BMJ Open. 2016 May 10;6(5):e010510
pubmed: 27165645
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Iran Red Crescent Med J. 2016 Jan 05;18(5):e23786
pubmed: 27478627
P T. 2016 Oct;41(10):623-634
pubmed: 27757001